Risk of digoxin intoxication in heart failure patients exposed to digoxin-diuretic interactions: A population-based study

British Journal of Clinical Pharmacology

Volumn 70, Issue 2, 2010, Pages 258-267

  Wang, Meng Ting ^a   Su, Chen Yi ^b   Chan, Agnes L F ^c   Lian, Pei Wen ^a   Leu, Hsin Bang ^d   Hsu, Yu Juei ^e  

^a Grad Inst of Pharmacognosy Science   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

digoxin intoxication; digoxin diuretic interactions; drug safety; nested case control study

Indexed keywords

DIGOXIN; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG INTOXICATION; ELECTROLYTE DISTURBANCE; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TAIWAN;

AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; DIGOXIN; DIURETICS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 77954489037     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03687.x     Document Type: Article

References (45)

1. Janchawee B, Wongpoowarak W, Owatranporn T, Chongsuvivatwong V. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther 2005 30 : 13 20.
2. Magro L, Conforti A, Del Zotti F, Leone R, Iorio ML, Meneghelli I, Massignani D, Visonà E, Moretti U. Identification of severe potential drug-drug interactions using an Italian general-practitioner database. Eur J Clin Pharmacol 2008 64 : 303 309.
3. Bennett S. Diuretics: use, actions and prescribing rationale. Nurse Prescribing 2008 6 : 72 7.
4. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 Focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009 119 : 1977 2016.
5. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 2008 10 : 933 989.
6. Hirsch AT, Dzau VJ, Creager MA. Baroreceptor function in congestive heart failure: effect on neurohumoral activation: effect on neurohumoral activation and regional vascular resistance. Circulation 1987 75 : IV36 48.
7. Gheorghiade M, Ferguson D. Digoxin. A neurohormonal modulator in heart failure? Circulation 1991 84 : 2171 2186.
8. Pervaiz MH, Dickinson MG, Yamani M. Is digoxin a drug of the past? Cleve Clin J Med 2006 73 : 821 834.
9. The Digitalis Investigation Group. The effects of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997 336 : 523 533.
10. Hood WB Jr., Dans AL, Guyatt GH, Jaeschke R, McMurray JJ. Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis. J Card Fail 2004 10 : 155 164.
11. Moser M. Do diuretics differ in terms of clinical outcome in congestive heart failure? Cardiovasc Drugs Ther 1997 11 (Suppl 273 277.
12. Allen LA, O'Connor CM. Management of acute decompensated heart failure. CMAJ 2007 176 : 797 805.
13. Follath F. Do diuretics differ in terms of clinical outcome in congestive heart failure? Eur Heart J 1998 19 (Suppl 5 8.
14. Howlett JG. Current treatment options for early management in acute decompensated heart failure. Can J Cardiol 2008 24 : 9B 13B.
15. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999 341 : 709 717.
16. Tatro DS, ed. Drug Interaction Facts™ 2007. The Authority on Drug Interactions.
17. Morgan DB, Davidson C. Hypokalaemia and diuretics: an analysis of publications. Br Med J 1980 280 : 905 908.
18. Eichhorn EJ, Gheorghiade M. Digoxin. Prog Cardiovasc Dis 2002 44 : 251 266.
19. Wilkerson RD. Acute effects of intravenous furosemide administration on serum digoxin concentration. Am Heart J 1981 102 : 63 5.
20. Steiness E, Olesen KH. Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy. Br Heart J 1976 38 : 167 172.
21. Lim P, Jacob E. Magnesium deficiency in patients on long-term diuretic therapy for heart failure. Br Med J 1972 3 : 620 622.
22. Whang R, Oei TO, Watanabe A. Frequency of hypomagnesemia in hospitalized patients receiving digitalis. Arch Intern Med 1985 145 : 655 656.
23. Hsiao FY, Yang CL, Huang YT, Huang WF. Using Taiwan's national health insurance research databases for pharmacoepidemiology research. J Food Drug Anal 2007 15 : 99 108.
24. Yang SY, Kao YH, Chong MY, Yang YH, Chang WH, Lai CS. Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study. Clin Pharmacol Ther 2007 81 : 586 594.
25. Chen CY, Chiu HF, Yeh MK, Chang CC, Yang CY. The use of anti-asthmatic medications among pediatric patients in Taiwan. Pharmacoepidemiol Drug Saf 2003 12 : 129 133.
26. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD, Resource Utilization Among Congestive Heart Failure (REACH) Study. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002 39 : 60 9.
27. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987 40 : 373 383.
28. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992 45 : 613 619.
29. De Bruin ML, van Hemel NM, Leufkens HG, Hoes AW. Hospital discharge diagnoses of ventricular arrhythmias and cardiac arrest were useful for epidemiologic research. J Clin Epidemiol 2005 58 : 1325 1329.
30. Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA. Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke 2006 37 : 1969 1974.
31. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005 43 : 1130 1139.
32. Goettsch WG, Heintjes EM, Kastelein JJ, Rabelink TJ, Johansson S, Herings RM. Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study. Pharmacoepidemiol Drug Saf 2006 15 : 435 443.
33. Gennari FJ. Hypokalemia. N Engl J Med 1998 339 : 451 458.
34. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989 79 : 340 349.
35. Chan ALF, Wang MT, Su CY, Tsai FH. Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study. Eur J Clin Pharmacol 2009 65 : 1237 1243.
36. Ward RE, Gheorghiade M, Young JB, Uretsky B. Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure. J Am Coll Cardiol 1995 26 : 93 101.
37. Lehmann HU, Witt E, Temmen L, Hochrein H. Life-threatening digitalis intoxication with and without additional diuretic treatment. Dtsch Med Wochenschr 1978 103 : 1566 1571.
38. Kjeldsen K, Norgaard A, Gheorghiade M. Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure. Cardiovasc Res 2002 55 : 710 713.
39. Katzung BG, Parmley WW. Drugs used in heart failure. In : Basic & Clinical Pharmacology, Ninth edn, ed. Katzung BG.
40. Brater DC, Morrelli HF. Digoxin toxicity in patients with normokalemic potassium depletion. Clin Pharmacol Ther 1977 22 : 21 33.
41. Steiness E. Digoxin toxicity compared with myocardial digoxin and potassium concentration. Br J Pharmacol 1978 63 : 233 237.
42. Hanratty CG, McGlinchey P, Johnston GD, Passmore AP. Differential pharmacokinetics of digoxin in elderly patients. Drug Aging 2000 17 : 353 362.
43. Waldorff S, Hansen PB, Egeblad H, Berning J, Buch J, Kjaergård H, Steiness E. Interactions between digoxin and potassium-sparing diuretics. Clin Pharmacol Ther 1983 33 : 418 423.
44. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003 289 : 1652 1658.
45. Juurlink DN, Mamdani MM, Kopp A, Herrmann N, Laupacis A. A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin. Br J Clin Pharmacol 2005 59 : 102 107.